TRPs to cardiovascular disease

José C. González-Cobos, Xuexin Zhang, Rajender K. Motiani, Kelly E. Harmon, Mohamed Trebak

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Transient receptor potential (TRP) is a large superfamily of cation channels comprising 28 members in mammals. TRP channels are ubiquitously expressed in human tissues, including the cardiovascular system where they have been associated with a number of physiological functions, such as proliferation, contraction, and migration. TRP channels comprise six large families of cation channels: TRPC, TRPM, TRPV, TRPP, TRPA, and TRPML with diverse ion selectivities and modes of activation. Depending on the isoform considered, activation of TRP channels can cause entry of Ca2+, Na+, or Mg2+ into cells. TRP channels have recently emerged as attractive drug targets for treatment of cardiovascular diseases since their expression and/or activation was shown to be disturbed in certain pathophysiological conditions, such as cardiac hypertrophy and hypertension. In this short review, we will summarize data on the expression of TRP channels in the three major cell types of the cardiovascular system: cardiomyocytes, endothelial cells, and smooth muscle cells and will review evidence for the involvement of TRP channels in mediating cardiovascular disease.

Original languageEnglish (US)
Title of host publicationTRP Channels in Drug Discovery
Subtitle of host publicationVolume II
Editors Arpad Szallasi, Tamas Biro
Pages3-40
Number of pages38
DOIs
StatePublished - Nov 19 2012

Publication series

NameMethods in Pharmacology and Toxicology
ISSN (Print)1557-2153
ISSN (Electronic)1940-6053

Fingerprint

Transient Receptor Potential Channels
Cardiovascular Diseases
TRPM Cation Channels
Cardiovascular System
TRPC Cation Channels
Cardiomegaly
Cardiac Myocytes
Smooth Muscle Myocytes
Cations
Mammals
Protein Isoforms
Endothelial Cells
Ions
Hypertension
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)

Cite this

González-Cobos, J. C., Zhang, X., Motiani, R. K., Harmon, K. E., & Trebak, M. (2012). TRPs to cardiovascular disease. In A. Szallasi, & T. Biro (Eds.), TRP Channels in Drug Discovery: Volume II (pp. 3-40). (Methods in Pharmacology and Toxicology). https://doi.org/10.1007/978-1-62703-095-3_1
González-Cobos, José C. ; Zhang, Xuexin ; Motiani, Rajender K. ; Harmon, Kelly E. ; Trebak, Mohamed. / TRPs to cardiovascular disease. TRP Channels in Drug Discovery: Volume II. editor / Arpad Szallasi ; Tamas Biro. 2012. pp. 3-40 (Methods in Pharmacology and Toxicology).
@inbook{aa0f05a039ef4f98be0fbd0ed61885da,
title = "TRPs to cardiovascular disease",
abstract = "Transient receptor potential (TRP) is a large superfamily of cation channels comprising 28 members in mammals. TRP channels are ubiquitously expressed in human tissues, including the cardiovascular system where they have been associated with a number of physiological functions, such as proliferation, contraction, and migration. TRP channels comprise six large families of cation channels: TRPC, TRPM, TRPV, TRPP, TRPA, and TRPML with diverse ion selectivities and modes of activation. Depending on the isoform considered, activation of TRP channels can cause entry of Ca2+, Na+, or Mg2+ into cells. TRP channels have recently emerged as attractive drug targets for treatment of cardiovascular diseases since their expression and/or activation was shown to be disturbed in certain pathophysiological conditions, such as cardiac hypertrophy and hypertension. In this short review, we will summarize data on the expression of TRP channels in the three major cell types of the cardiovascular system: cardiomyocytes, endothelial cells, and smooth muscle cells and will review evidence for the involvement of TRP channels in mediating cardiovascular disease.",
author = "Gonz{\'a}lez-Cobos, {Jos{\'e} C.} and Xuexin Zhang and Motiani, {Rajender K.} and Harmon, {Kelly E.} and Mohamed Trebak",
year = "2012",
month = "11",
day = "19",
doi = "10.1007/978-1-62703-095-3_1",
language = "English (US)",
isbn = "9781627030946",
series = "Methods in Pharmacology and Toxicology",
pages = "3--40",
editor = "Szallasi, { Arpad} and { Biro}, Tamas",
booktitle = "TRP Channels in Drug Discovery",

}

González-Cobos, JC, Zhang, X, Motiani, RK, Harmon, KE & Trebak, M 2012, TRPs to cardiovascular disease. in A Szallasi & T Biro (eds), TRP Channels in Drug Discovery: Volume II. Methods in Pharmacology and Toxicology, pp. 3-40. https://doi.org/10.1007/978-1-62703-095-3_1

TRPs to cardiovascular disease. / González-Cobos, José C.; Zhang, Xuexin; Motiani, Rajender K.; Harmon, Kelly E.; Trebak, Mohamed.

TRP Channels in Drug Discovery: Volume II. ed. / Arpad Szallasi; Tamas Biro. 2012. p. 3-40 (Methods in Pharmacology and Toxicology).

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - TRPs to cardiovascular disease

AU - González-Cobos, José C.

AU - Zhang, Xuexin

AU - Motiani, Rajender K.

AU - Harmon, Kelly E.

AU - Trebak, Mohamed

PY - 2012/11/19

Y1 - 2012/11/19

N2 - Transient receptor potential (TRP) is a large superfamily of cation channels comprising 28 members in mammals. TRP channels are ubiquitously expressed in human tissues, including the cardiovascular system where they have been associated with a number of physiological functions, such as proliferation, contraction, and migration. TRP channels comprise six large families of cation channels: TRPC, TRPM, TRPV, TRPP, TRPA, and TRPML with diverse ion selectivities and modes of activation. Depending on the isoform considered, activation of TRP channels can cause entry of Ca2+, Na+, or Mg2+ into cells. TRP channels have recently emerged as attractive drug targets for treatment of cardiovascular diseases since their expression and/or activation was shown to be disturbed in certain pathophysiological conditions, such as cardiac hypertrophy and hypertension. In this short review, we will summarize data on the expression of TRP channels in the three major cell types of the cardiovascular system: cardiomyocytes, endothelial cells, and smooth muscle cells and will review evidence for the involvement of TRP channels in mediating cardiovascular disease.

AB - Transient receptor potential (TRP) is a large superfamily of cation channels comprising 28 members in mammals. TRP channels are ubiquitously expressed in human tissues, including the cardiovascular system where they have been associated with a number of physiological functions, such as proliferation, contraction, and migration. TRP channels comprise six large families of cation channels: TRPC, TRPM, TRPV, TRPP, TRPA, and TRPML with diverse ion selectivities and modes of activation. Depending on the isoform considered, activation of TRP channels can cause entry of Ca2+, Na+, or Mg2+ into cells. TRP channels have recently emerged as attractive drug targets for treatment of cardiovascular diseases since their expression and/or activation was shown to be disturbed in certain pathophysiological conditions, such as cardiac hypertrophy and hypertension. In this short review, we will summarize data on the expression of TRP channels in the three major cell types of the cardiovascular system: cardiomyocytes, endothelial cells, and smooth muscle cells and will review evidence for the involvement of TRP channels in mediating cardiovascular disease.

UR - http://www.scopus.com/inward/record.url?scp=84869032651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869032651&partnerID=8YFLogxK

U2 - 10.1007/978-1-62703-095-3_1

DO - 10.1007/978-1-62703-095-3_1

M3 - Chapter

AN - SCOPUS:84869032651

SN - 9781627030946

T3 - Methods in Pharmacology and Toxicology

SP - 3

EP - 40

BT - TRP Channels in Drug Discovery

A2 - Szallasi, Arpad

A2 - Biro, Tamas

ER -

González-Cobos JC, Zhang X, Motiani RK, Harmon KE, Trebak M. TRPs to cardiovascular disease. In Szallasi A, Biro T, editors, TRP Channels in Drug Discovery: Volume II. 2012. p. 3-40. (Methods in Pharmacology and Toxicology). https://doi.org/10.1007/978-1-62703-095-3_1